Holocene Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-641,700
Closed -$49.4M 712
2020
Q2
$49.4M Buy
+641,700
New +$49.2M 0.43% 71

Other funds holding GILD

Holocene Advisors's GILD Position: Q2 2026 in Review

Holocene Advisors increased its Gilead Sciences (GILD) stake by 23% in Q2 2026, buying an estimated $79.7M and bringing the position to 3,216,892 shares worth $406M. The position accounts for 0.92% of the portfolio, ranked #17.

Holocene Advisors first reported a position in GILD in Q4 2017 and has held it in 11 quarters since. The position peaked at $511M in Q4 2025. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Holocene Advisors held 3,216,892 shares of Gilead Sciences worth $406M as of Q2 2026.
  • Holocene Advisors bought 605,066 Gilead Sciences shares in Q2 2026, an estimated $79.7M.
  • Gilead Sciences made up 0.92% of Holocene Advisors's portfolio in Q2 2026, its #17 holding.
  • Holocene Advisors first reported a position in Gilead Sciences in Q4 2017 and has held it in 11 quarters since.
  • Holocene Advisors's Gilead Sciences position peaked at $511M in Q4 2025.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Holocene Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.